Opportunity Information: Apply for TI 18 015
The State Opioid Response Grants (SOR) opportunity is a federal funding program run by the Substance Abuse and Mental Health Services Administration (SAMHSA) under the U.S. Department of Health and Human Services. Released for fiscal year 2018, it is designed to help states and territories strengthen and speed up their response to the opioid crisis by expanding prevention, treatment, and recovery efforts focused specifically on opioid use disorder (OUD). The program emphasizes reducing unmet need for treatment and lowering opioid overdose deaths tied to prescription opioids, heroin, and increasingly dangerous illicit fentanyl and fentanyl analogs.
A central priority of SOR is scaling up medication-assisted treatment (MAT) using the three FDA-approved medications for OUD. While the notice does not list them by name, these medications are commonly understood in federal OUD policy to be methadone, buprenorphine, and naltrexone. The grants are intended to increase access to these medications as part of evidence-based care, alongside appropriate psychosocial interventions and recovery supports. In practice, this means states are expected not only to fund clinical services, but also to strengthen the systems that make treatment easier to start, maintain, and successfully complete.
Funding is distributed primarily by formula to state and territorial governments, rather than through a purely competitive selection process. In addition, the program includes a targeted funding feature: a 15 percent set-aside reserved for the ten states with the highest overdose mortality rates. This design reflects the reality that the epidemic has hit some jurisdictions disproportionately hard and aims to direct extra resources to the places with the greatest burden of overdose deaths.
Applicants are required to ground their approach in data and clear system planning. States must use epidemiological data to identify and document the most critical gaps in OUD treatment availability, including where gaps exist geographically (for example, rural or underserved regions), demographically (such as populations experiencing higher risk or poorer access), and at the service level (like shortages in prescribers, detox capacity, outpatient access, or recovery supports). Beyond identifying needs, states must describe evidence-based implementation strategies and system design models that can close those gaps quickly and effectively. The expectation is that states will select approaches proven to work and demonstrate how their chosen model will expand capacity and improve outcomes at scale.
States receiving SOR funds must deliver evidence-based treatment interventions that include FDA-approved OUD medications, paired with psychosocial services where appropriate, and must track and report their progress. Reporting focuses on two major outcomes: increasing the availability and use of medication-assisted treatment and reducing opioid-related overdose deaths. The grant is framed as a supplement to the work state agencies are already doing, supporting a more comprehensive statewide response rather than replacing existing programs. Because of that, the funding must supplement and not supplant current opioid prevention, treatment, and recovery activities, meaning states cannot simply substitute federal dollars for money they already budgeted for the same purposes.
The opportunity also stresses that a complete response goes beyond prescribing medication. States are expected to use assessments to identify both gaps and existing resources, then build on current prevention and treatment infrastructure as well as community-based recovery support services. Applicants must explain how they will expand access not only to treatment, but also to recovery supports that help people stabilize and sustain long-term recovery, such as peer services, recovery housing supports, employment-related supports, and other community-based services, as allowed under the grant framework.
Prevention is another required component, and it is meant to be coordinated with other federal efforts so that strategies are aligned rather than duplicative. This can include activities aimed at reducing initiation of opioid misuse, improving prescribing and pain-management practices through evidence-based approaches, strengthening community prevention initiatives, and improving overdose prevention measures, as long as the work fits within the program rules and is connected to reducing OUD and overdose harms.
A specific operational expectation in the grant is improving retention in care. States must describe how they will keep people engaged in treatment over time, recognizing OUD as a chronic condition for many individuals. The notice highlights using a chronic care model or another innovative approach that has already shown success in improving retention. This focus reflects a key challenge in OUD systems: treatment access matters, but sustained engagement is often what drives lower relapse risk, reduced overdose risk, and better long-term health and social outcomes.
From the source details, the opportunity is a discretionary grant (Funding Opportunity Number TI 18 015) under CFDA 93.788, open to eligible applicants that are state governments. It was created on June 14, 2018, with an original application deadline of August 13, 2018. The notice lists an award ceiling of $930,000,000 and an expected 59 awards, which aligns with the number of states and territories typically eligible for formula-based SAMHSA funding.Apply for TI 18 015
- The Department of Health and Human Services, Substance Abuse and Mental Health Services Adminis in the health sector is offering a public funding opportunity titled "State Opioid Response Grants" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.788.
- This funding opportunity was created on Jun 14, 2018.
- Applicants must submit their applications by Aug 13, 2018. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $930,000,000.00 in funding.
- The number of recipients for this funding is limited to 59 candidate(s).
- Eligible applicants include: State governments.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
State Opioid Response (SOR) Grants (FY 2018) - FAQs
1) What is the State Opioid Response (SOR) Grants program?
The State Opioid Response (SOR) Grants program is a federal funding opportunity administered by the Substance Abuse and Mental Health Services Administration (SAMHSA) under the U.S. Department of Health and Human Services. For fiscal year 2018, it is designed to help states and territories strengthen and accelerate their response to the opioid crisis by expanding opioid use disorder (OUD) prevention, treatment, and recovery efforts.
2) What is the main goal of the SOR opportunity?
The program aims to reduce unmet need for OUD treatment and lower opioid overdose deaths associated with prescription opioids, heroin, and increasingly illicit fentanyl and fentanyl analogs. It emphasizes rapid, statewide improvements in access to evidence-based care and measurable reductions in overdose mortality.
3) Which federal agency runs SOR, and under what department?
SOR is run by SAMHSA, which is part of the U.S. Department of Health and Human Services.
4) Who is eligible to apply for this grant opportunity?
Based on the notice details provided, eligible applicants are state governments (including states and territories). The program is structured primarily for state and territorial government applicants rather than individual providers applying directly.
5) Is SOR a competitive grant or formula funding?
Funding is distributed primarily by formula to state and territorial governments rather than through a purely competitive selection process. This structure is intended to ensure broad coverage across jurisdictions while still directing resources to areas with greater need.
6) What is the 15 percent set-aside mentioned in the SOR program?
The program includes a targeted funding feature: a 15 percent set-aside reserved for the ten states with the highest overdose mortality rates. This is meant to direct additional resources to the states experiencing the greatest burden of overdose deaths.
7) What is Medication-Assisted Treatment (MAT), and why is it central to SOR?
A central priority of SOR is scaling up medication-assisted treatment (MAT) for OUD using the three FDA-approved medications for OUD. The grant emphasizes expanding access to these medications as part of evidence-based care, along with psychosocial interventions and recovery supports where appropriate.
8) Which FDA-approved OUD medications does SOR focus on?
The notice does not list the medications by name, but the three FDA-approved medications commonly referenced in federal OUD policy are methadone, buprenorphine, and naltrexone. The program priority is to increase access to FDA-approved OUD medications as part of evidence-based treatment.
9) Does SOR fund only medication, or does it support other services too?
SOR is not limited to prescribing medications. States are expected to deliver evidence-based treatment interventions that include FDA-approved OUD medications and, where appropriate, pair medication treatment with psychosocial services. The program also expects states to build on prevention and treatment infrastructure and to expand community-based recovery support services as allowed under the grant framework.
10) What types of recovery support activities are expected under SOR?
The opportunity stresses expanding recovery supports that help people stabilize and sustain long-term recovery. Examples mentioned include peer services, recovery housing supports, employment-related supports, and other community-based services, as allowed under the grant framework.
11) Is prevention required under SOR?
Yes. Prevention is described as a required component of a complete response, and it is intended to be coordinated with other federal efforts so strategies are aligned rather than duplicative. Prevention can include reducing initiation of opioid misuse, improving prescribing and pain-management practices through evidence-based approaches, strengthening community prevention initiatives, and improving overdose prevention measures, provided these activities fit within the program rules and are connected to reducing OUD and overdose harms.
12) How are states expected to decide what needs to be funded?
States are required to ground their approach in epidemiological data and clear system planning. They must use data to identify and document the most critical gaps in OUD treatment availability, including geographic gaps (such as rural or underserved areas), demographic gaps (populations at higher risk or with poorer access), and service-level gaps (such as shortages in prescribers, detox capacity, outpatient access, or recovery supports).
13) What must applicants describe in their implementation plan?
Applicants must describe evidence-based implementation strategies and system design models that can close identified gaps quickly and effectively. The expectation is that states will select approaches proven to work and explain how the chosen model will expand capacity and improve outcomes at scale.
14) What is meant by improving "retention in care" in the SOR notice?
Improving retention in care is a specific operational expectation. States must describe how they will keep people engaged in treatment over time, recognizing OUD as a chronic condition for many individuals. The notice highlights using a chronic care model or another innovative approach that has already shown success in improving retention.
15) What outcomes are states expected to track and report?
States must track and report progress focused on two major outcomes: (1) increasing the availability and use of medication-assisted treatment (MAT) and (2) reducing opioid-related overdose deaths.
16) What does "supplement and not supplant" mean for SOR funds?
The grant is framed as a supplement to work state agencies are already doing. "Supplement and not supplant" means states cannot use SOR dollars to replace (substitute for) existing state funding they already budgeted for the same opioid prevention, treatment, and recovery activities.
17) Is SOR meant to replace existing state opioid programs?
No. The opportunity describes SOR as supporting a more comprehensive statewide response rather than replacing existing programs. It is intended to build on current prevention and treatment infrastructure and expand capacity where gaps and unmet needs exist.
18) What kind of gaps does SOR want states to address?
The notice emphasizes identifying and closing gaps in OUD treatment availability and system capacity, including geographic gaps (rural/underserved regions), demographic gaps (groups with higher risk or limited access), and service-level gaps (prescriber shortages, detox capacity, outpatient access, and recovery supports).
19) What is the Funding Opportunity Number (FON) for this SOR notice?
The Funding Opportunity Number provided is TI 18 015.
20) What is the CFDA number associated with this opportunity?
The CFDA number listed for this opportunity is 93.788.
21) What type of grant is this described as?
The source details describe this as a discretionary grant opportunity.
22) When was this opportunity created, and what was the application deadline?
The opportunity was created on June 14, 2018, with an original application deadline of August 13, 2018.
23) What is the award ceiling and expected number of awards?
The notice lists an award ceiling of $930,000,000 and an expected 59 awards, which aligns with the number of states and territories typically eligible for formula-based SAMHSA funding.
24) What substances and overdose risks does SOR specifically highlight?
The program highlights overdose deaths tied to prescription opioids, heroin, and increasingly dangerous illicit fentanyl and fentanyl analogs, reflecting shifting patterns in opioid-related harms.
25) What does the SOR notice suggest about "systems" work beyond direct services?
In practice, states are expected not only to fund clinical services but also to strengthen the systems that make treatment easier to start, maintain, and successfully complete. This includes planning based on assessments of gaps and existing resources, then building on current infrastructure and recovery support services to improve access and outcomes statewide.
Browse more opportunities from the same category: Health
Next opportunity: DoD Reconstructive Transplant Investigator- Initiated Research Award
Previous opportunity: DoD Kideny Cancer, Technology Development Award
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for TI 18 015
Applicants also applied for:
Applicants who have applied for this opportunity (TI 18 015) also looked into and applied for these:
| Funding Opportunity |
|---|
| HIV-Focused Population Surveys in Countries Supported Under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH19 1941 Funding Number: CDC RFA GH19 1941 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $75,000,000 |
| Rural Communities Opioid Response Program - Planning Apply for HRSA 18 116 Funding Number: HRSA 18 116 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Multi-Sectoral Nutrition, Maternal, Newborn and Child Health Activity Apply for RFI 617 18 MCH N Funding Number: RFI 617 18 MCH N Agency: Agency for International Development, Uganda USAID-Kampala Category: Health Funding Amount: Case Dependent |
| Service Area Competition-Additional Areas (SAC-AA) – Chicago, IL and Toledo, OH Apply for HRSA 19 091 Funding Number: HRSA 19 091 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| CSELS Partnership: Strengthening Public Health Laboratories Apply for CDC RFA OE15 15010401SUPP18 Funding Number: CDC RFA OE15 15010401SUPP18 Agency: Department of Health and Human Services, Centers for Disease Control - CSELS Category: Health Funding Amount: $24,000,000 |
| Service Area Competition Apply for HRSA 19 013 Funding Number: HRSA 19 013 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Partnership with China CDC on Infectious Disease Prevention and Control in China and Globally Apply for CDC RFA GH18 1855 Funding Number: CDC RFA GH18 1855 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Tribal Opioid Response Grants Apply for TI 18 016 Funding Number: TI 18 016 Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Adminis Category: Health Funding Amount: $50,000,000 |
| Strengthening Applied Epidemiology and Sustainable International Public Health Capacity through the Field Epidemiology Training Programs Apply for CDC RFA GH15 16190401SUPP18 Funding Number: CDC RFA GH15 16190401SUPP18 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $20,000,000 |
| NIA AD/ADRD Health Care Systems Research Collaboratory (U54 - Clinical Trial Required) Apply for RFA AG 19 009 Funding Number: RFA AG 19 009 Agency: Department of Health and Human Services, National Institutes of Health Category: Health Funding Amount: Case Dependent |
| AIDS Drug Assistance Program (ADAP) Emergency Relief Funds (ERF) Apply for HRSA 19 028 Funding Number: HRSA 19 028 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Preventive Health and Health Services Block Grant– 2018 Apply for CDC RFA OT18 1805 Funding Number: CDC RFA OT18 1805 Agency: Department of Health and Human Services, Centers for Disease Control - OSTLTS Category: Health Funding Amount: Case Dependent |
| Limited Competition: Human Heredity and Health in Africa Consortium Biorepository (U24 Clinical Trial Not Allowed) Apply for RFA RM 18 020 Funding Number: RFA RM 18 020 Agency: Department of Health and Human Services, National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| Integrative Omics to Enhance Therapeutics Development for Healthy Aging (UH2/UH3 Clinical Trial Not Allowed) Apply for RFA AG 19 011 Funding Number: RFA AG 19 011 Agency: Department of Health and Human Services, National Institutes of Health Category: Health Funding Amount: $3,300,000 |
| Health Equity and Financial Protection Platform (HEFPP) Apply for 72049218APS00001 03 Funding Number: 72049218APS00001 03 Agency: Agency for International Development, Philippines USAID-Manila Category: Health Funding Amount: $11,500,000 |
| Global Health Security Partnership Engagement: Expanding Efforts and Strategies to Protect and Improve Public Health Globally Apply for CDC RFA GH15 16320401SUPP18 Funding Number: CDC RFA GH15 16320401SUPP18 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $5,000,000 |
| Global Health Security Partnership Engagement: Expanding Efforts and Strategies to Protect and Improve Public Health Globally Apply for CDC RFA GH15 16210401SUPP18 Funding Number: CDC RFA GH15 16210401SUPP18 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Protecting and Improving Public Health Globally: Building and Strengthening Public Health Impact, Systems, Capacity, and Security Apply for CDC RFA GH15 16270301SUPP18 Funding Number: CDC RFA GH15 16270301SUPP18 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $2,000,000 |
| Partnering with Regional Institutes to Strengthen Essential Public Health Functions in Vietnam Apply for CDC RFA GH16 17180301SUPP18 Funding Number: CDC RFA GH16 17180301SUPP18 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $1,000,000 |
| Health Leadership Project (HLP) Apply for 72052118RFA00005 Funding Number: 72052118RFA00005 Agency: Agency for International Development, Haiti USAID-Port Au Prince Category: Health Funding Amount: $15,000,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "TI 18 015", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.